Subspecialties

You can’t predict the future, but a lot can be learned by analyzing what happened in the past.

Sitting Down With Walter Wrobel, CEO/ President, and Reinhard Rubow, CFO, Retina Implant AG

Cataract surgery and IOL implantation have come a long way since the 1990s, and it appears that technical innovations are stoking demand more than medical need.

Why we need a rethink of the surgical approach to the barrier between the anterior and posterior lens segments

Creation of the anterior capsulorhexis is a key stage in cataract surgery, and producing a precise rhexis is of paramount importance. The most commonly used technique to achieve this during phacoemulsification is continuous curvilinear capsulorhexis (CCC).

In the UK, real-world visual outcomes of patients receiving ranibizumab for neovascular AMD fail to match those achieved in most randomized trials. But they were delivered with substantially fewer injections and hospital visits.

An unexpected and simple advance has made stem cell production much easier and safer. Do STAP stem cells bring the treatment, even cure, of ocular disease a lot closer?

A new drug, ALG-1001, that blocks the transmembrane receptors that cells use to attach to their surroundings, has the potential to treat a range of retinovascular diseases

Intracorneal ring segment and phakic IOL implantation: a refractive solution for patients with keratoconus and high myopia

Practical pearls and possible pitfalls for the general cataract surgeon